Crossmark

Salivary S100 calcium-binding protein beta (S100B) and neurofilament light (NfL) after acute exposure to repeated head impacts in collegiate water polo players

Crossref DOI link: https://doi.org/10.1038/s41598-022-07241-0

Published Online: 2022-03-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Monroe, Derek C.

Thomas, Elizabeth A.

Cecchi, Nicholas J.

Granger, Douglas A.

Hicks, James W.

Small, Steven L.
Funding

Funding for this research was provided by:

National Institutes of Health (5TL1TR001415-04)
License Information

Text and Data Mining valid from 2022-03-02

Version of Record valid from 2022-03-02
More Information

Article History

Received: 3 September 2021

Accepted: 4 February 2022

First Online: 2 March 2022

Competing interests

: NJC is founder and CEO of Counter, Inc. a company that manufactures and sells water polo equipment, including protective headgear. DAG is founder and Chief Scientific and Strategy Advisor at Salimetrics LLC and Salivabio LLC. These relationships are managed by the policies of the committees on conflict of interest at Johns Hopkins University School of Medicine and the University of California at Irvine. None of the other authors have any potential conflicts.

Document is current

Any future updates will be listed below